Key result
A combined approach of surgical hemostasis, substitution of blood products, hemodialysis, and rFVIIa safely stopped severe hirudin-induced bleeding in a patient with HIT II and chronic renal failure.
Why the study?
Does a combined approach of surgical hemostasis, blood products, hemodialysis, and rFVIIa stop severe hirudin-induced bleeding in a patient with HIT II and chronic renal failure after cardiac surgery?
Case Report (n=1)
Does a combined approach of surgical hemostasis, blood products, hemodialysis, and rFVIIa stop severe hirudin-induced bleeding in a patient with HIT II and chronic renal failure after cardiac surgery?
A combined approach including rFVIIa and hemodialysis may be effective for managing severe hirudin-induced bleeding in cardiac surgery patients with renal failure and HIT II.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for combined hemostasis including rFVIIa in hirudin bleeding; prospective studies needed before clinical adoption.
Heparin-induced thrombocytopenia type II (HIT II) requires alternative anticoagulation. Hirudin has been effectively used in patients with HIT II scheduled for cardiac surgery. However, bleeding complications were observed in patients with renal impairment. In vitro hemodialysis (HD) has been questioned over its efficacy in eliminating hirudin. Another approach to stop bleeding is the application of recombinant factor VIIa (rFVIIa). We report on a patient with HIT II and chronic renal failure who suffered from severe hirudin-induced bleeding after cardiac surgery who was safely treated with a combined approach of surgical hemostasis, substitution of blood products, HD, and rFVIIa to stop finally bleeding.
No takes yet. Share an insight, caveat, or question.
Hein et al. (2005) conducted a case report in Heparin-induced thrombocytopenia type II (HIT II) and chronic renal failure with severe hirudin-induced bleeding (n=1). Combined approach of surgical hemostasis, substitution of blood products, hemodialysis, and recombinant factor VIIa (rFVIIa) was evaluated on Bleeding cessation. A combined approach of surgical hemostasis, substitution of blood products, hemodialysis, and rFVIIa safely stopped severe hirudin-induced bleeding in a patient with HIT II and chronic renal failure.
Synapse has enriched 10 related papers. Consider them for comparative context: